TH24376A - - Google Patents
Info
- Publication number
- TH24376A TH24376A TH9501002686A TH9501002686A TH24376A TH 24376 A TH24376 A TH 24376A TH 9501002686 A TH9501002686 A TH 9501002686A TH 9501002686 A TH9501002686 A TH 9501002686A TH 24376 A TH24376 A TH 24376A
- Authority
- TH
- Thailand
- Prior art keywords
- alkyl
- replaced
- amino
- formula
- methyl
- Prior art date
Links
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract 20
- 150000001875 compounds Chemical class 0.000 claims abstract 16
- 239000000126 substance Substances 0.000 claims abstract 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 9
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 6
- 239000001257 hydrogen Substances 0.000 claims abstract 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 6
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims abstract 4
- 229940079593 drug Drugs 0.000 claims abstract 4
- 239000000203 mixture Substances 0.000 claims abstract 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims abstract 3
- 150000001204 N-oxides Chemical class 0.000 claims abstract 3
- 150000008043 acidic salts Chemical class 0.000 claims abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract 2
- 238000002360 preparation method Methods 0.000 claims abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 9
- 125000005843 halogen group Chemical group 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 6
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 claims 5
- 238000006467 substitution reaction Methods 0.000 claims 5
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 4
- -1 aryl tetrazole Chemical class 0.000 claims 4
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 claims 4
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 2
- XILPCSMEKCBYFO-UHFFFAOYSA-N 4-methyl-1,2,4-triazole Chemical compound CN1C=NN=C1 XILPCSMEKCBYFO-UHFFFAOYSA-N 0.000 claims 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 239000000543 intermediate Substances 0.000 claims 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 1
- 241001024304 Mino Species 0.000 claims 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- 229950003476 aminothiazole Drugs 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000006073 displacement reaction Methods 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- WHLAXDUXKMECTM-UHFFFAOYSA-N oxadiazol-4-amine Chemical compound NC1=CON=N1 WHLAXDUXKMECTM-UHFFFAOYSA-N 0.000 claims 1
- 230000020477 pH reduction Effects 0.000 claims 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- 150000003536 tetrazoles Chemical class 0.000 claims 1
- 238000011287 therapeutic dose Methods 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 125000004953 trihalomethyl group Chemical group 0.000 claims 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 239000003524 antilipemic agent Substances 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH24376A true TH24376A (cs) | 1997-03-25 |
| TH17753B TH17753B (cs) | 2004-10-05 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI895261A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten (1,2-bentsisoksatsol-3-yyli)-1-piperidinyylialkyyli-6,7,8,9-tetrahydro-4H-pyrido/1,2-a/pyrimidinonijohdannaisten valmistamiseksi | |
| ATE126216T1 (de) | Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung. | |
| YU31303A (sh) | Jedinjenja imidazola sa pripojenim arilom ili heteroarilom kao anti-inflamatorni i analgetički agensi | |
| WO2002060492A1 (en) | Methods of inhibiting kinases | |
| FI112483B (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-[2-[4-(6-fluori-1,2-bentsisoksatsol-3-yyli) -1-piperidinyyli]etyyli]-2-alkyyli-pyrimidin-4-onijohdannaisten valmistamiseksi | |
| PH23607A (en) | Amide derivatives and pharmaceutical composition containing said compounds | |
| ES8706668A1 (es) | Un procedimiento para la preparacion de derivados de piperidina. | |
| CA2233285A1 (en) | Pyrazolopyrimidines as crf receptor antagonists | |
| US4232022A (en) | Heterocyclic compounds | |
| ZA200604528B (en) | Polycyclic agents for the treatment of respiratory syncytial virus infections | |
| CA2203274A1 (en) | Apolipoprotein-b synthesis inhibitors | |
| NO20021448L (no) | Nye tiazolo-(4,5-D)pyrimidinforbindelser | |
| KR960037675A (ko) | 벤조니트릴 및 벤조플루오라이드 | |
| KR950032185A (ko) | 신규한 단일환상 및 이중환상 dna 자이레이즈 저해제 | |
| HUT50333A (en) | Process for producing pharmaceutical compositions comprising 1h-imidazoles and 1h-1,2,4-triazoles as active ingredient and process for producing the active ingredients | |
| MY132062A (en) | Apolipoprotein-b synthesis inhibitors | |
| HUT46536A (en) | Process for producing antianxietive pharmaceutical compositions | |
| TH24376A (cs) | ||
| TH17753B (cs) | ||
| IL101820A0 (en) | Chemical compounds | |
| LTIP1733A (en) | Novel bicyclic amino-substituted compounds, process for their preparation and pharmaceutical preparation | |
| JPS55154948A (en) | 11phenyll22aminoethanol derivative* its manufacture and medicine containing it and having antiinflammatory activity for local administration | |
| GR3033175T3 (en) | Trifluoromethylsulfonylphenyl or trifluoromethylsulfinylphenyl group containing 2-cyano-3-hydroxy-propenamide derivatives, process for their preparation, their use as medicaments and pharmaceutical compositions containing them | |
| AU8372791A (en) | 1,3-dioxan-5-yl alkenoic acids, processes of preparation and pharmaceutical compositions containing them | |
| TH20641A (th) | 6-[ไทรแอโซลิล[3-(ไทรฟลูออโรเมธิล)เฟนิล]เมธิล]-2-ควิโนลิโนนและ-ควิโนลีนไธโอน |